Medicared For All Logo

Mark Dersch in Ocala, Florida

Home Florida Ocala

Mark Dersch has Urology as his primary medical specialty. Their primary office is: 1901 Se 18th Ave in Ocala, Florida. There is an additional office location, for a total of two, for Mark Dersch that can be viewed further down.

They're a part of the: Advanced Urology Institute Llc medical group which has around 108 members. You can call their office at 352-351-1313 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Indiana University School Of Medicine and graduated in 1989 (around 35 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.


Mark W Dersch Office Phone and Directions

Mark Dersch
Advanced Urology Institute Llc
1901 Se 18th Ave
Ocala, Florida 34471
352-351-1313


Patient Ratings
Please rate your experience with Mark Dersch below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 352-351-1313


Enter a starting address:


Healthcare Info for Mark Dersch

Medical School: Indiana University School Of Medicine
Graduation Year: 1989
The Primary Medical Specialty for Mark Dersch is listed as: Urology
Approximate Years of Experience: 35
PAC (PECOS ID)#: 3870577174
NPI #: 1538119151
NPI Created On: 05/12/2006
NPI Last Updated Listed as: 12/22/2020
Primary Taxonomy Code: 208800000X
License Number:
ME66575
Listed Gender: Male

Insurance, Services, Charges


Forms of insurance accepted by include, but are not limited to:

  • Humana
  • Blue Cross Blue Shield
  • Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.


Services and Procedures include:

  1. Insertion of needle into vein for collection of blood sample
  2. Shock wave crushing of kidney stones
  3. Insertion of indwelling bladder catheter
  4. Ultrasound measurement of bladder capacity after voiding
  5. Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
  6. Biopsy of prostate gland
  7. Mri scan of pelvis before and after contrast
  8. X-ray of abdomen, 1 view
  9. Ct scan of abdomen and pelvis
  10. Ct scan of abdomen and pelvis before and after contrast
  11. Ultrasound of rectum
  12. Ultrasound of rectum
  13. Automated urinalysis test
  14. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  15. Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle
  16. New patient office or other outpatient visit, typically 30 minutes
  17. New patient office or other outpatient visit, typically 45 minutes
  18. Established patient office or other outpatient visit, typically 5 minutes
  19. Established patient office or other outpatient visit, typically 10 minutes
  20. Established patient office or other outpatient visit, typically 15 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788357229

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788357231

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $38

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788357233

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Drug or Biological: Drug

Product Category #2: Oncology

Name Of Drug #2:: BALVERSA

Associated Drug #2: 59676-030-56


Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792751511

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: HYPERHYDROSIS

Name of Drug #1: BOTOX

Open Associated Drug #1: 0023-1145-01


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792751513

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: HYPERHYDROSIS

Name of Drug #1: BOTOX

Open Associated Drug #1: 0023-1145-01


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 792751515

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: HYPERHYDROSIS

Name of Drug #1: BOTOX

Open Associated Drug #1: 0023-1145-01


Payments Total: $24

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 828515789

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Genetic Disease

Name of Drug #1: OXLUMO

Open Associated Drug #1: 71336-1002-1


Payments Total: $3,000

Number of Payments:: 4

Form of Payment: Dividend, profit or other return on investment

Ownership Interest: Yes

Record ID:: 834590267

Being Disputed:: No

Product Related: No


Payments Total: $18

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 828638035

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Urology

Name of Drug #1: GEMTESA

Open Associated Drug #1: 73336-075-30


Payments Total: $16

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 828638065

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Urology

Name of Drug #1: GEMTESA

Open Associated Drug #1: 73336-075-30


Additional Office Locations

1. Advanced Urology Institute Llc
12109 County Rd
Oxford, FL 34484
Suite 103
Group Members: 108

Phone: 352-351-1313

Enter a starting address:


Urology Professionals in Ocala

2850 Se 3rd Ct
Ocala, FL
Norman H. Anderson, Md, Pa

9401 Sw Hwy 200
Ocala, FL
Norman H. Anderson, Md, Pa

2850 Se 3rd Ct
Ocala, FL
Norman H. Anderson, Md, Pa

1901 Se 18th Ave
Ocala, FL
Advanced Urology Institute Llc

1752 Sw 1st Ave
Ocala, FL

6600 Sw Hwy 200
Ocala, FL
Essential Medical Services Llc

Providers in Advanced Urology Institute Llc

1.Angelika Agudelo

1901 Se 18th Ave
Ocala Fl 34471-8214
Advanced Urology Institute Llc
Nurse Practitioner

2.Rajinikanth Ayyathurai

609 W Highland Blvd
Inverness Fl 34452-4638
Advanced Urology Institute Llc
Urology

3.Jonathan Baron

240 Southpark Cir E
Saint Augustine Fl 32086-5137
Advanced Urology Institute Llc
Physician Assistant

4.Jonathan Baron

506 Palmetto St
New Smyrna Beach Fl 32168-7325
Advanced Urology Institute Llc
Physician Assistant

5.Yaser Bassel

12780 Race Track Rd
Tampa Fl 33626-1393
Advanced Urology Institute Llc
Urology

6.Yaser Bassel

35095 Us Hwy 19 N
Palm Harbor Fl 34684-1971
Advanced Urology Institute Llc
Urology

View all 108 members of Advanced Urology Institute Llc medical group